<p><b>TABLE OF INTERACTIONS WITH</b></p>

<p><b>ROXITHROMYCIN</b></p>

<p><b>See also: macrolides (except spiramycin)</b></p>

<p><b>From the French ANSM drug interactions document of September 2016, p. 197</b></p>

<table cellspacing="0" cellpadding="0" border="1">
<tbody>
<tr>
<td valign="top"><p><b>ROXITHROMYCIN</b></p>

<p><b>RxNorm: 9478 </b></p>

<p><b>ATC: J01FA06</b></p></td>
<td valign="top"><p><b>ATORVASTATIN</b></p>

<p><b>RxNorm: 83367 </b></p>

<p><b>ATC: C10AA05</b></p></td>
<td valign="top"><p>Increased risk of undesirable effects (concentration dependent) of the rhabdomyolysis type</p></td>
<td valign="top"><p><b>Precaution for use</b></p>

<p>Use weaker doses of the cholesterol lowering medication</p></td>
</tr>

<tr>
<td valign="top"><p><b>ROXITHROMYCIN</b></p>

<p><b>RxNorm: 9478 </b></p>

<p><b>ATC: J01FA06</b></p></td>
<td valign="top"><p><b>CICLOSPORIN</b></p>

<p><b>RxNorm: 3008 </b></p>

<p><b>ATC: L04AD01 S01XA18</b></p></td>
<td valign="top"><p>Risk of increase of the blood concentrations of ciclosporin and of the creatinemia</p></td>
<td valign="top"><p><b>Precaution for use</b></p>

<p>Blood concentration dosage of the ciclosporin, testing of renal function, and adjustment of the dosage during the administration with the macrolide and after it is stopped<b>. </b></p></td>
</tr>

<tr>
<td valign="top"><p><b>ROXITHROMYCIN</b></p>

<p><b>RxNorm: 9478 </b></p>

<p><b>ATC: J01FA06</b></p></td>
<td valign="top"><p><b>MIDAZOLAM</b></p>

<p><b>RxNorm: 6960</b></p>

<p><b>ATC: N05CD08</b></p></td>
<td valign="top"><p>Slight increase of sedation</p></td>
<td valign="top"><p><b>Take into account</b></p></td>
</tr>

<tr>
<td valign="top"><p><b>ROXITHROMYCIN</b></p>

<p><b>RxNorm: 9478 </b></p>

<p><b>ATC: J01FA06</b></p></td>
<td valign="top"><p><b>SIMVASTATIN</b></p>

<p><b>RxNorm: 36567 </b></p>

<p><b>ATC: C10AA01</b></p></td>
<td valign="top"><p>Increased risk of undesirable effects (concentration dependent) of the rhabdomyolysis type</p></td>
<td valign="top"><p><b>Precaution for use</b></p>

<p>Use weaker doses of the cholesterol lowering medication</p></td>
</tr>

<tr>
<td valign="top"><p><b>ROXITHROMYCIN</b></p>

<p><b>RxNorm: 9478 </b></p>

<p><b>ATC: J01FA06</b></p></td>
<td valign="top"><p><b>SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES</b></p>

<p><b>CLASS CODE: </b></p>

<p><b>C01-N05</b></p></td>
<td valign="top"><p>Increased risk of ventricular arrhythmias, especially of torsades de pointes</p></td>
<td valign="top"><p><b>Precaution for use</b></p>

<p>Clinical monitoring and EKG during the administration of these substances together.</p></td>
</tr>

<tr>
<td valign="top"><p><b>ROXITHROMYCIN</b></p>

<p><b>RxNorm: 9478 </b></p>

<p><b>ATC: J01FA06</b></p></td>
<td valign="top"><p><b>THEOPHYLLINE (AND, BY EXTRAPOLATION, AMINOPHYLLINE)</b></p>

<p><b>CLASS CODE: </b></p>

<p><b>R03DA</b></p></td>
<td valign="top"><p>Risk of increase of the theophyllinemia, particularly with children</p></td>
<td valign="top"><p><b>Take into account</b></p></td>
</tr>

</tbody>
</table>

